Pharmafile Logo
Pharmafocus logo
Advanced Search

vaccines

Showing 15 posts of 183 posts found.

CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates

May 9, 2023
Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines

CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …

News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines, 2021

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …

News

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …

News

World’s first COVID-19 vaccine booster study launches in UK

May 20, 2021
COVID-19, UK government, booster vaccine, clinical trial, vaccines

The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …

News

Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains

March 12, 2021
Medical Communications COVID-19, Novavax, vaccines

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …

News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021
Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

News

Affinivax receives $22m funding for development of Staphylococcus aureus vaccine

March 10, 2021
Research and Development Affinivax, bacteria, vaccines

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …

News

Valo and ImmunoScape collaboration identifies immunogenic peptides for pan-coronavirus vaccine

March 9, 2021
Manufacturing and Production COVID-19, Valo Therapeutics, immunoscape, vaccines

Immunotherapy platform developer Valo Therapeutics has successfully completed a collaboration with the biotechnology company ImmunoScape to identify immunogenic peptides for …

News

Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine

March 5, 2021
Medical Communications COVID-19, CureVac, Novartis, vaccines

CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the …

News
houses_of_parliament_london_7654658782

UK government invests £5m in COVID-19 mRNA vaccine library

March 5, 2021
Medical Communications COVID-19, CPI, government, vaccines

The Centre for Process Innovation (CPI) has received a £5 million investment from the UK government, to support the development …

News

ConserV and eTheRNA partner on infectious disease vaccines

March 4, 2021
ConserV, eTheRNA, vaccines

ConserV Bioscience and eTheRNA immunotherapies have agreed to collaborate on the development of vaccine candidates for infectious diseases. ConserV is …

News

FDA approves Johnson & Johnson’s COVID-19 vaccine for emergency use

March 1, 2021
Sales and Marketing COVID-19, Janssen, Johnson & Johnson, vaccines

The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in …

News
who_flag

WHO backs AstraZeneca vaccine against South African variant

February 9, 2021
Manufacturing and Production COVID-19, WHO, vaccines

World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …

News

Johnson & Johnson’s single-shot COVID-19 vaccine 85% effective

February 1, 2021
Sales and Marketing COVID-19, Johnson & Johnson, vaccines

Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …

News
1920px-city_of_london_skyline_from_london_city_hall_-_sept_2015_-_crop

New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …

News
News alerts and subscriptions

Latest content

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

June 2, 2023

BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910

June 2, 2023

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023

FDA approves ANDA of 20mg generic Nitisinone capsules

June 1, 2023